Policy Submissions Policy Submissions PolicyStrategic Agreement 2022-2027 Health Technology Assessment (HTA) Access to Medicines Working Group (AMWG) Clinical TrialsClinical Trial Research Agreements Indemnity & Compensation Guidelines Research & Development Taskforce (RDTF) Teletrials Oncology Industry TaskforceAddressing the challenges of access to new cancer medications About the OIT Reports and resources Pharma Australia Inclusion Group (PAIG) Policy Submissions Regenerative Medicines Consortium Programme 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2025 TGA’s consultation: ‘Medicine shortages and discontinuations: Proposed changes to reporting requirements’ Wednesday, 15 January 2025